DSM-Firmenich AG (XSWX:DSFIR) Notes Receivable: CHF0 Mil (As of Dec. 2025)


XSWX:DSFIR DSM-Firmenich AG XSWX:DSFIR
32 GF Score
Price CHF74.82
GF Value CHF69.93
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is DSM-Firmenich AG Notes Receivable?

DSM-Firmenich AG XSWX:DSFIR +5.62% 32 Notes Receivable is CHF0 Mil as of Dec. 2025. GuruFocus rates XSWX:DSFIR with a GF Score™ of 32/100 and a GF Value™ of CHF69.93 (Fairly Valued). The stock has 5 warning signs investors should review.

DSM-Firmenich AG's Notes Receivable for the quarter that ended in Dec. 2025 was CHF0 Mil.

DSM-Firmenich AG Notes Receivable Related Terms

DSM-Firmenich AG Notes Receivable Historical Data

* Premium members only.

The historical data trend for DSM-Firmenich AG's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DSM-Firmenich AG Notes Receivable Chart

DSM-Firmenich AG Annual Data
Trend Dec21 Dec23 Dec24 Dec25
Notes Receivable
0.00 0.00 0.00 0.00

DSM-Firmenich AG Semi-Annual Data
Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
XSWX:DSFIR
32GF Score
DSM-Firmenich AG XSWX:DSFIR
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DSM-Firmenich AG Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of CHF0 Mil mean?
DSM-Firmenich AG (XSWX:DSFIR) has a Notes Receivable of CHF0 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on DSM-Firmenich AG and its competitors.
Is DSM-Firmenich AG's Notes Receivable too high?
DSM-Firmenich AG's current Notes Receivable is CHF0 Mil. Overall, DSM-Firmenich AG has a GF Score™ of 32/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's Notes Receivable compare to LIN and SHW?
DSM-Firmenich AG's Notes Receivable of CHF0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Chemicals company?
A good Notes Receivable depends on the Chemicals industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on DSM-Firmenich AG and its competitors. DSM-Firmenich AG's current Notes Receivable is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (XSWX:DSFIR) is currently considered Fairly Valued. The stock's GF Value™ is CHF69.93, compared to a current price of CHF74.82 — trading 7% above its estimated fair value. The current Notes Receivable is CHF0 Mil. DSM-Firmenich AG's overall GF Score™ is 32/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For DSM-Firmenich AG (XSWX:DSFIR), the current Notes Receivable is CHF0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DSM-Firmenich AG (XSWX:DSFIR) Overvalued in 2026?

Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued. The current stock price of CHF74.82 is trading 7% above its estimated GF Value™ of CHF69.93. GuruFocus considers DSM-Firmenich AG to be Fairly Valued.

Key valuation signals for XSWX:DSFIR:

  • Notes Receivable: CHF0 Mil
  • GF Value™: CHF69.93 vs. price of CHF74.82 (7% above fair value)
  • GF Score™: 32/100 with 5 warning signs

No single metric tells the full story. See the XSWX:DSFIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DSM-Firmenich AG Business Description

Address Wurmisweg 576, Kaiseraugst, CHE, 4303
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
32GF Score

Get the complete analysis for XSWX:DSFIR

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF74.82
Price
CHF69.93
GF Value